Fig 1.
The Siriraj Health (SIH) study.
(A) Geographic distribution of Siriraj Health study (marked area) in the center of Bangkok, Thailand; (B) Flow diagram of participants enrolled in the Siriraj Health cohort study; FU, Follow-up; SIH, Siriraj Health. Reprinted under a CC BY license, with permission from Ms. Apinya Surawit, original copyright [2024].
Table 1.
Demographic data of the participants in the cohort.
Table 2.
Characteristics of the participants based on self-report diabetes status.
Fig 2.
Comparative analysis of pre-diabetes (Pre-DM) and type 2 diabetes (T2DM) to those without T2DM at baseline, and risk assessment for Pre-DM and T2DM development during follow-up, DLP, dyslipidemia; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; MetS, metabolic syndrome; WC, waist circumference.
Table 3.
Cross-sectional analysis comparing pre-diabetesa (n = 1,055) and type 2 diabetes mellitusb (n = 279) to those without diabetesc (n = 3,487) at baseline (SIH1 and SIH2).
Table 4.
Changes in risk factors from baseline (SIH1) and follow-up (SIH1) and relative risk of developing pre-diabetesa (n = 120) or type 2 diabetes mellitusb (n = 48) in follow-up among individuals with normal blood glucose levelsc (N = 2,309) at baseline.
Fig 3.
Average predicted probabilities of remaining with normal blood glucose levels, developing pre-diabetes (Pre-DM), or developing type 2 diabetes (T2DM) in follow-up among participants with normal blood glucose levels (n = 2,477) at baseline.
BMI, body mass index; MetS, metabolic syndrome; WC, waist circumference; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; BP, blood pressure.
Table 5.
Genotypic variants of type 2 diabetes related single nucleotide polymorphisms association comparing pre-diabetes and type 2 diabetes mellitus to those without diabetes (control).